雅虎香港搜尋

- Analysis: Stelara patent deal puts J&J back on path to $57 bln 2025 revenue forecast
  Reuters· 15 分鐘前
  Stelara, introduced in 2009, has been J&J’s top-selling drug since 2019, with sales reaching $9.7 billion in 2022. Its patents ...
- Analysis: Debt-ceiling deal ignores US debt time bomb
  Reuters· 9 分鐘前
  Republicans and Democrats are touting a hastily-written debt ceiling deal that staves off a devastating U.S. default, but ...
- Hollywood actors set vote to authorize strike with writers still out
  Reuters· 18 分鐘前
  Hollywood's actors union will announce Monday whether their members authorized a possible strike, a move that would turn ...

雅虎香港 搜尋